Cover: Modified Capitation and Treatment Incentives for End Stage Renal Disease

Modified Capitation and Treatment Incentives for End Stage Renal Disease

Published In: Health Care Financing Review, v. 17, no. 3, 1996, p. 129-142

Posted on on January 01, 1996

by Donna O. Farley, Grace M. Carter, Joel Kallich, Thomas W. Lucas, Karen Spritzer

Develops a modified capitation payment method for the Medicare end stage renal disease (ESRD) program designed to support appropriate treatment choices and protect health plans from undue financial risk. The payment method consists of risk-adjusted monthly capitated payments for individuals on dialysis or with functioning kidney grafts, lump sum event payments for expected incremental costs of kidney transplantations or graft failures, and outlier payments for expensive patients. The methodology explained 25 percent of variation in annual payments per patient. Risk adjustment captured substantial variations across patient groups. Outlier payments reduced health plan risk by up to 15 percent.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.